Figures & data
Figure 1 Canonical Wnt signaling.
Abbreviation: APC, adenomtous polyposis coli.
![Figure 1 Canonical Wnt signaling.](/cms/asset/ee79641c-2145-4239-8565-70aa57878250/drbi_a_53823_f0001_c.jpg)
Figure 2 Noncanonical Wnt signaling.
Abbreviations: RYK, receptor tyrosine kinase; ROR, receptor tyrosine kinase-like orphan receptor; ROCK, Rho-associated protein kinase; MAPKKK, mitogen-activated protein kinases; MAPKK, mitogen-activated protein kinases and AP1, activator protein 1.
![Figure 2 Noncanonical Wnt signaling.](/cms/asset/3fef85a0-819e-4fb9-85a2-62f763e9cdbf/drbi_a_53823_f0002_c.jpg)
Table 1 Clinically approved nonspecific Wnt antagonist
Table 2 Clinical trials of Wnt inhibitors/modulators
Figure 3 Schematic of Wnt inhibitors currently in clinical trials.
Abbreviations: Dsh, dishevelled; CK1α, casein kinase 1α; GSK3β, glycogen synthase kinase 3β; APC, adenomatous polyposis coli; TCF/LEF, T-cell factor/lymphoid enhancer factor; CBP, cyclic AMP response element-binding protein.
![Figure 3 Schematic of Wnt inhibitors currently in clinical trials.](/cms/asset/171d9428-84c8-4f51-9b19-fd55e01be0a4/drbi_a_53823_f0003_c.jpg)